These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20075653)

  • 1. Torsade de pointes after ziprasidone overdose with coingestants.
    Alipour A; Cruz R; Lott RS
    J Clin Psychopharmacol; 2010 Feb; 30(1):76-7. PubMed ID: 20075653
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
    Joy JP; Coulter CV; Duffull SB; Isbister GK
    Clin Pharmacol Ther; 2011 Aug; 90(2):243-5. PubMed ID: 21716272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
    Teng PR; Shen TY; Lai TJ
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253
    [No Abstract]   [Full Text] [Related]  

  • 6. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Biswas AK; Zabrocki LA; Mayes KL; Morris-Kukoski CL
    J Toxicol Clin Toxicol; 2003; 41(1):79-82. PubMed ID: 12645973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective observational multi-poison center study of ziprasidone exposures.
    Klein-Schwartz W; Lofton AL; Benson BE; Spiller HA; Crouch BI
    Clin Toxicol (Phila); 2007; 45(7):782-6. PubMed ID: 17926152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Biswas AK; Zabrocki LA; Mayes KL; Morris-Kukoski CL
    J Toxicol Clin Toxicol; 2003; 41(2):101-4. PubMed ID: 12733844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone overdose.
    Burton S; Heslop K; Harrison K; Barnes M
    Am J Psychiatry; 2000 May; 157(5):835. PubMed ID: 10784487
    [No Abstract]   [Full Text] [Related]  

  • 11. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital Holter measurement of QT prolongation in ziprasidone overdose.
    Berling I; Isbister GK; Calver L; Clunas S
    Clin Toxicol (Phila); 2011 Aug; 49(7):694-6. PubMed ID: 21819290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
    Berling I; Isbister GK
    Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.
    de Gregorio C; Morabito G; Cerrito M; Dattilo G; Oreto G
    Int J Cardiol; 2011 Apr; 148(2):226-8. PubMed ID: 19540606
    [No Abstract]   [Full Text] [Related]  

  • 15. [QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
    Züchner H
    Dtsch Med Wochenschr; 2002 May; 127(18):983-4. PubMed ID: 11987023
    [No Abstract]   [Full Text] [Related]  

  • 16. QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
    Manini AF; Raspberry D; Hoffman RS; Nelson LS
    J Med Toxicol; 2007 Dec; 3(4):178-81. PubMed ID: 18072173
    [No Abstract]   [Full Text] [Related]  

  • 17. [Citalopram and Torsades de Pointes. A case report].
    Meuleman C; Jourdain P; Bellorini M; Sadeg N; Loiret J; Guillard N; Thebault B; Funck F
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1021-4. PubMed ID: 11603066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of antipsychotics used in bipolar illness.
    Piepho RW
    J Clin Psychiatry; 2002; 63 Suppl 4():20-3. PubMed ID: 11913671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone for sedation of the agitated ED patient.
    Martel ML
    Am J Emerg Med; 2004 May; 22(3):238. PubMed ID: 15138973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.